Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bone|January 23, 2013
Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formationGregor Sisask, Richard Marsell, Anna Sundgren-Andersson, et al.Endocrinology|February 28, 2004
Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasisTobias Larsson, Richard Marsell, Ernestina Schipani, et al.The Journal of Endocrinology|October 4, 2007
Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cellsTijana Krajisnik, Peyman Björklund, Richard Marsell, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 15, 2018
Non-invasive tri-modal visualisation via PET/SPECT/μCT of recombinant human bone morphogenetic protein-2 retention and associated bone regeneration: A proof of conceptGry Hulsart-Billström, Ram Kumar Selvaraju, Sergio Estrada, et al.Bone|December 7, 2011
GSK-3 inhibition by an orally active small molecule increases bone mass in ratsRichard Marsell, Gregor Sisask, Yvonne Nilsson, et al.European Journal of Endocrinology|January 2, 2008
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly menRichard Marsell, Elin Grundberg, Tijana Krajisnik, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individualsMajd A I Mirza, Johan Alsiö, Ann Hammarstedt, et al.Pageof 2